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Background: Smokers who are unwilling or unable to quit smoking may benefit from using nicotine replacement
therapy (NRT) for harm reduction. This may include the partial or complete substitution of cigarettes with NRT.
A taxonomy of the characteristics of those using NRT for harm reduction would be helpful in tailoring advice and
treatment. Although attempts to categorize those using NRT for harm reduction have been made, these have largely
been based on quantitative data. In order to provide further in-depth exploration of views, beliefs and experiences,
the current study probed issues surrounding NRT and harm reduction qualitatively to better understand barriers and
facilitators to this approach.
Methods: Three groups of participants (n = 15) were recruited from a student sample: current smokers with a history
of NRT use, smokers without a history of NRT use, and ex-smokers with a history of NRT use. Participants were asked
about their demographic characteristics, smoking behaviours, intention and perceived ability to quit smoking,
awareness and use of NRT, beliefs about the health consequences of using NRT, and the safety and efficacy of
NRT, using semi-structured telephone interviews.
Results: Twenty-four themes were identified; these themes were clustered into three main issues of cross-cutting
themes: attitudes towards smoking and motivation to quit; smoking reduction and quit attempts; and beliefs, use and
concerns about NRT. Those with a history of NRT use were more motivated and engaged with the quitting process
than non-users. However, irrespective of smoking status and past NRT use, all participants showed misperceptions
about NRT, such as the health consequences associated with NRT use.
Conclusions: NRT users are more motivated to quit smoking than non-users and are more likely to employ techniques
to assist their cessation attempts. The majority of smokers have misperceptions regarding the safety and efficacy of
NRT which may act as a barrier to its usage.
Keywords: Harm reduction, Smoking, NRT, Long-term useBackground
Harm reduction aims to lessen the negative effects from
smoking without complete cessation [1]. This can be
done in a number of ways, including the partial or
complete substitution of cigarettes with safer nicotine
replacement therapy products (NRT). Partial replace-
ment includes using NRT as a means to achieve smoking
reduction (SR; cutting down the number of cigarettes
smoked) or for periods of temporary abstinence (TA;* Correspondence: kabaysilla@hotmail.com
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In contrast, complete substitution involves replacing all
cigarettes with NRT often to prevent relapse. Substantial
evidence supports the use of harm reduction. In both
clinical trials and population-based studies, the partial
substitution of cigarettes with NRT increases smokers’
propensity to stop smoking and in certain circumstances
results in significant reductions in cigarette consumption
(which may be associated with reduced immediate harm)
[1,2]. Studies have also demonstrated that the long-term
use of NRT following smoking cessation helps to prevent
relapse to smoking [3].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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smoking has been estimated to be responsible for the
death of 12% of all adults aged 30 years and older [5]. In
2012, a national survey estimated cigarette smoking
prevalence in England at 20 per cent (using a sample of
21,330) and quitting numbers (i.e. quitters per year)
were 6.2 per cent of 4,726 participants. In 2014, the
same survey found that smoking prevalence was 18.5%
of 15, 206 respondents and cessation had risen to 7.5
per cent of a sample of 3,147 [6]. However, despite
changes in regulation, particularly in the UK where NRT
is licensed for harm reduction purposes and recom-
mended as a tobacco control policy [7]; few smokers use
NRT long-term to prevent relapse or to help reduce their
cigarette intake [1,8]. Consequently, there is a need to
identify ways in which we can encourage smokers,
attempting to cut down, to use NRT (the most effective
method) and better still, encourage smokers who are un-
able or unwilling to quit nicotine, to substitute their
cigarettes completely with safer NRT products. A suitable
first step is to develop a typology of smokers who use and
do not use NRT for partial or complete substitution in
order to tailor interventions to encourage smokers to use
NRT and aid their cessation attempts. Previous quantita-
tive surveys have shown that the partial substitution of
cigarettes with NRT is more common among married
smokers with high nicotine dependence and is associated
with age, ethnicity and social-economic status [9]. More-
over, long-term NRT use appears to be more common
among older, female smokers of higher socio-economic
status who are more dependent on cigarettes [10].
These findings are insightful as they reveal the socio-
demographic profile of smokers attempting harm reduction
with NRT. However, it is not feasible to develop a full
taxonomy through the use of quantitative data alone;
response categories tend to be of closed format or fixed.
Although this inflexibility allows for easy comparison
across participants, it restricts the richness of information
obtained. Qualitative research can fill this gap.
The following study investigates the beliefs and views
regarding NRT and tobacco use, of ex-smokers with a
history of NRT use, smokers with a history of NRT use,
and smokers who have never used medicinal nicotine
products. We aim to determine the characteristics of
those who engage in NRT use and to identify the barriers
and facilitators of the use of medicinal nicotine in order to
inform harm reduction policies and interventions aimed
at smokers who struggle to stop smoking.
Methods
Design and procedure
Three groups of participants were recruited via an email
advertisement to all UCL students: current smokers with
a history of NRT use, smokers without a history of NRTuse, and ex-smokers with a history of NRT use. These
three groups were chosen in order to provide an insight
into the various stages of the decision processes involved
in using or not using NRT and reasons for continued
use and associated success or failure to stop. We chose a
student population as it was easily accessible in the re-
cruitment phase, providing a suitable mix of NRT naïve
and NRT experienced smokers and ex-smokers. Add-
itionally, within the current and ex-smokers with a his-
tory of NRT use groups, there were a mixture of people
who were and were not using NRT at the time. Partici-
pants had to be 18+ years of age, speak English and be in
good health. Information regarding NHS stop smoking
services was offered to participants after the interview,
and they were compensated for their time with a £10
high street voucher. Participants were provided with
information sheets about the purpose of the study and
informed consent was obtained from all participants.
Ethical approval was granted by the UCL Research Ethics
Committee. This study complies with the RATS guidelines.
A semi-structured interview design was used to provide
guidance, but also to obtain an in-depth understanding
of the issues. The telephone interviews were conducted
between May and June 2012. The interviews lasted no
longer than 30 minutes and were recorded via a telephone
recorder. A current smoker was defined as a person who
reported having smoked at least 100 cigarettes in their
lifetime and who currently smokes every day or on most
days. Additionally, as three months therapy is the standard
time frame given to smokers who chose to use NRT for
harm reduction in the UK [7] and due to the fact that it
may be difficult to find participants that have been using
NRT for a longer period of time, the long-term use of
NRT was defined to be 3 months and longer, which allows
for the inclusion of more participants in the target pool
from which selection took place.
Participants
134 smokers and ex-smokers respond to the advertisement
of whom 105 could not be contacted. Of the 29 that were
left, 2 failed to meet the inclusion criteria. The first 15
participants (5 from each group) that responded and met
the inclusion criteria took part in the study as a sample size
of 15 was judged adequate to reach saturation [11].
Measures
Topic guides for the interviews were developed from
existing literature, PRIME theory [12] and based on find-
ings from a previous quantitative study [10]. The survey
instrument included questions on the following subjects:
demographic characteristics, smoking behaviours, intention
and perceived ability to quit smoking, awareness and use of
NRT, beliefs about the health consequences of using medi-
cinal nicotine, and the safety and efficacy of NRT.
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needs of each group of participants and covered 1) current
smoking behaviour; 2) beliefs, views and experience of
smoking; 3) their current goals; 4) views about NRT; 5)
whether they were using NRT and why; 6) which products
they were using; 7) their views on the harmfulness and
effectiveness of NRT; 8) their knowledge of the current
regulations of NRT; 9) other forms of treatment to quit
smoking. The interview schedules included questions such
as; “What are your views, beliefs and experience of smok-
ing?”; “What are your views about NRT?”; “What are your
thoughts about long-term NRT use?”; and “Have you tried
anything else to quit smoking?”
Data analysis
Interviews were recorded and transcribed verbatim. Tran-
scripts were analysed by KS using framework analysis [13]
to identify recurring themes and patterns within the data.
Framework analysis allowed us to examine differences
between the three groups and look for explanations for
any differences identified. This was done using five key
stages. This first involved becoming familiar with the
interview transcripts by rereading in order to identify
emerging key themes and sub-themes. Following this,
concepts were then indexed to corresponding themes and
applied to the framework. The final stage of the process
involved analysing the key characteristics by making com-
parisons and explanations from the data.
Internal validity was attained by using ‘deviant case
analysis’ and the ‘constant comparative’ method. A number
of transcripts were randomly selected and read by another
coder (EB) in order to establish external validity [14]. This
coder verified that the transcripts were analysed reliably
and that that the information included supported the stud-
ies’ main findings.
Results
Of the sample of 15 participants, 9 were male and 6
were female, with an average age of 27 years (SD ± 7.9).
Seven identified themselves as White British, three
White, two Chinese, two White Chinese and one White
American. The respondents reported smoking for an
average of 11 years (SD ± 7.5). Current smokers also
stated that they have a cigarette consumption of 11 ciga-
rettes per day (SD ± 5.9). Ex-smokers revealed that their
previous cigarette consumption averaged at 22 cigarettes
per day (SD ± 4.5).
Those with a history of NRT use (i.e. ex-smokers and
current smokers that have used or are currently using
NRT; [mean = 27, SD = 2.17]; [mean = 32; SD = 10.98]
respectively), were older than smokers who have not
used NRT (mean = 22, SD = 2.17). In regards to cigarette
consumption, those with a history of NRT use generally
smoked more cigarettes daily (ex-smokers with a historyof NRT use [mean = 22, SD = 4.47]; smokers with a history
of NRT use [mean = 15, SD = 5.55]) than smokers without
a history of NRT use (mean = 8, SD = 4.34). Long-term
NRT use (lasting beyond the standard 3 months of
therapy) was found amongst 60% of the ex-smokers
and 10% of the current smokers with a history of NRT.
Ex-smokers and current smokers with a history of NRT
use stated that they have tried the nicotine gum,
patches and lozenges.
Twenty-four themes were identified; eighteen of which
were deemed relevant to the proposed aims of the study:
to determine the characteristics of those who engage in
the use of NRT; and to identify the barriers and facilita-
tors of the use of medicinal nicotine. These themes have
been clustered into 3 main issues of cross-cutting themes
(Table 1): attitudes towards smoking and motivation to
quit; smoking reduction and quit attempts; and beliefs,
use and concerns about NRT. These issues are discussed
below. The main themes and sub-themes that may play a
role in whether harm reduction is employed are detailed
in Table 2. Additional themes can be found in Additional
file 1: Table S1.
Issue 1: attitudes towards smoking and motivation to quit
Respondents from each group expressed negative attitudes
towards smoking and stated that they regret having
started smoking (Table 2) primarily due to the addictive-
ness of cigarettes and the health consequences of smoking.
Ex-smokers and smokers with a history of NRT use gener-
ally indicated that these reasons were the motivating
factors for wanting to quit:
‘[Regret starting because] I haven’t been able to stop.
And because yeah it’s expensive and addicting and
disgusting and deadly yeah… I would quit if I could,
I’m trying.’ (GZ, 29 year old female, smoker NRT).
Although smokers without a history of NRT use also
shared these views and stated that they regret smoking
because of their inability to quit, a few stated that they are
not yet ready to quit. The perception of needing to want
to quit (which was generally viewed as a prerequisite to
the quitting process) may influence the use of NRT as
smokers may not want to use NRT unless they are ready
to quit smoking. This suggests that smokers do not
understand that the use of NRT is potentially valuable in
helping them strengthen the want to quit smoking.
‘If the person’s a bit sort of ambivalent about whether
they want to quit or not, then NRT is not going to be
that much help. If they’re ready to kind of just quit
anyway then yeah NRT is going to aid them to do
that. But it just depends on how much the person
wants to quit.’ (MW, 22 year old male, smoker NRT).
Table 1 Factors that may influence whether smoking reduction or cessation occurs, and which may encourage NRT usage
Issue Factors Similarities Differences Associated sub-themes*
1. Attitudes towards smoking and
motivation to quit
Negative attitudes, emotions,
and experience of smoking
All groups 1.1, 3.1, 4.1
Factors that encourage quitting ExNRT, sNRT 3.2
sNRT 3.3
ExNRT 3.4
The role of motivation and





Smoking cessation as a future goal All groups 8.1





Behavioural methods to assist cessation ExNRT, SNRT 11.3
ExNRT 11.1, 11.2
Stop smoking services SNRT 24.1, 24.2
3. Beliefs, use and concerns about NRT Factors that will encourage the use of NRT ExNRT, SNRT 12.1, 12.4
SNRT 12.5
sNRT 15.1, 15.2
Incorrect/under-use of NRT ExNRT, SNRT 16.2
Short-term use of NRT ExNRT, SNRT 17.1
Long-term use of NRT ExNRT 17.2
Knowledge about NRT All groups 18.1
Concerns about NRT All groups 19.1, 19.2, 19.4
ExNRT, SNRT 19.5
SNRT, sNRT 19.3
Recommend NRT and other forms of therapy All groups 22.1, 23.2
Ex-NRT = Ex-smoker NRT; SNRT = Smoker NRT sNRT = Smoker no NRT; *Detailed in Table 2.
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smokers revealed that they had plans to quit smoking
(Table 2), these plans were often vague and set sometime
in the distant future. Respondents failed to detail whether
sub-goals were set; whether they wanted to quit abruptly,
or cut down gradually. Only one smoker with a history of
NRT use indicated that they would use NRT as an aid.
This demonstrates that transforming intention into behav-
iour is quite difficult as intentions do not always trigger a
behavioural response.
Issue 2: smoking reduction and quit attempts
A few respondents used a variety of techniques to
gradually cut down cigarette consumption (Table 2)
such as reducing the number of cigarettes smoked,
(which was used by smokers who have no history ofNRT use) but this was not found to be very effective.
Not smoking in the morning was tried by respondents
with a history of NRT use in order to cut down
cigarette consumption.
The most common method used for previous quit at-
tempts by all groups was abrupt quitting (Table 2), which
involved going ‘cold turkey’ for as long as possible. Again,
respondents who used this method believed that willpower
and motivation are the most important factors involved
when quitting and this determination influences the success
of the quit attempt.
‘I didn’t use anything, any aids or whatever, I just
stopped smoking. Erm… I think because I just had
the right motivation.’ (CS, 25 year old female, smoker
no NRT).
Table 2 Main themes that may influence whether
smokers engage in harm reduction
Theme Sub-theme
1. Views on smoking 1.1 Hostility towards smoking




4. Emotions connected with
smoking initiation
4.1 Regret starting
6. Beliefs that influence quit
attempts
6.1 Control of nicotine
dependence
6.2 Motivation and willpower
6.3 Confidence
7. Difficulties quitting/cutting down 7.4 Lack of motivation
8. Goals 8.1 Smoking cessation
9. Methods used to quit smoking 9.1 Abrupt
9.2 Cut down first
10. Methods of cutting down 10.1 Not smoking as many
cigarettes
10.2 Not smoking in the morning
10.3 Smoking only part of
the cigarette





12. Reasons for using NRT 12.1 To aid quit attempt
12.4 To help with cravings
12.5 Rid of habit
15. Factors to encourage
use of NRT
15.1 Free samples
15.2 Aid quit attempt
16. Use of NRT 16.2 Incorrect use/underuse
17. Length of NRT use 17.1 Short-term
17.2 Long-term
18. Knowledge about NRT 18.1 Current regulations
19. Concerns about NRT 19.1 Addiction
19.2 Harmful when used long-term
19.3 Effective
19.4 Health consequences
19.5 Delays quitting process
22. Helpfulness of NRT 22.1 Recommend
23. Recommendation of
cessation aids
23.2 Other forms of therapy
24. Stop smoking services 24.1 Advantages
24.2 Disadvantages
Themes and sub-themes included focus on the associated themes in Table 2.
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of motivation and employed distraction techniques to
support their quit attempts. Exercising was used by ex-
smokers and smokers with a history of NRT use in order
to keep them busy and feel healthier which in turn
encouraged them to abstain from smoking. These non-
medical aids were only employed by those with a history
of NRT use (Table 2). Additionally, only a minority of re-
spondents had used the stop smoking services suggesting
that individuals are either unaware of their availability, or
do not believe that they have a need for it. Smokers with a
history of NRT use credited the stop smoking service for
providing information regarding withdrawal symptoms
prior to the experience of withdrawal. However, this ser-
vice was criticised by smokers with a history of NRT use
for being over-reliant on NRT for smoking cessation.
Issue 3: beliefs, use and concerns about NRT
Respondents with a history of NRT use indicated that
they are aware of the function of NRT as they decided to
use medicinal nicotine in order to aid their quit attempt;
help with cravings and to modify some behavioural pat-
terns and situational cues that became associated with
smoking. For example, smoking after a meal or whilst
drinking alcohol.
‘I think I thought that if I used, like any of the NRT
things and when I have that moment [of craving], and
I felt like I couldn’t overpower it, I would be able to if
I had some nicotine [NRT].’ (AT, 32 year old female,
ex-smoker NRT).
Also, the cost of NRT played a big role in whether
smokers invested in them (a view shared by both ex-
smokers and smokers who have never used NRT). Non-
users indicated that they would be encouraged to use
NRT if they were able to collect free samples to test how
effective the products are, whereas other said that they
would use medicinal nicotine to assist their quit attempt if
they knew that it would increase their chances (Table 2).
‘I guess what can be done is NRT should probably be
given free samples to smokers when they try first so
that they will actually understand how it works and
whether it is effective for them.’ (GL, 22 year old
male, smoker no NRT).
Amongst NRT users, ex-smokers reported using it for
longer periods of time than smokers (Table 2). Ex-smokers
revealed a determination to quit smoking, and used NRT
for such a long time in order to prevent relapse. However,
ex and current smokers with a history of NRT use were
worried about transferring their nicotine addiction to NRT,
which resulted in short-term, incorrect or under-use use of
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adhere to the specific instructions given regarding how
each NRT product should be administered, the frequency
of use and the dosage. This demonstrates that smokers
have concerns and misperceptions about medicinal nico-
tine with regards to addictiveness, believing that it may
act as a gateway back into smoking. Each group of respon-
dents had mixed feelings about whether using NRT long-
term is harmful but generally believed that using NRT is
less harmful than smoking cigarettes.
‘Compared to smoking it’s probably virtually no harm
compared to smoking… I’d be very surprised if they
were approved and sold on the national health system
if they were going to do that much harm to you.’
(MW, 22 year old male, smoker NRT).
In terms of the effectiveness, current smokers believed
that NRT is efficacious to a certain extent and may only
work for some individuals. Smokers and ex-smokers
thought that using NRT may have health consequences
even though they were not sure what to attribute these
health consequences to. NRT users also believed that
using medicinal nicotine delays the quitting process as
their withdrawal symptoms lasted longer. Despite this, the
majority of ex-smokers and smokers with a history of
NRT use (Table 2) would recommend NRT but would set
conditions on their recommendation based on the length
of time that NRT should be used for in order to prevent
dependence. This suggests that although the majority of
respondents believed that use of NRT is safer than smok-
ing, they still held misconceptions about NRT that may
act as a barrier towards its use. All groups of respondents
also suggested that they would recommend both NRT and
other forms of therapy, indicating that smokers would like
additional support when attempting to quit.
Discussion
This study aimed to determine the barriers and facilitators
of the use of medicinal nicotine; and to determine the
characteristics of those who engage in the use of NRT; in
order to find ways to encourage smokers to engage in
harm reduction.
All groups of smokers were found to hold negative
opinions about smoking. Smokers with a history of NRT
use appeared motivated to want and attempt to quit
whereas those without a history of NRT use seemed to
lack this motivation. Those using NRT long-term were
characterised as being highly motivated to quit smoking,
engaged in various methods to assist their quit attempts
such as exercising and employing distraction techniques,
and revealed that they used medicinal nicotine as it greatly
assisted their cessation goal and helped to maintain their
motivation to quit.The current study also identified a number of barriers
and facilitators of the use of medicinal nicotine. One
barrier was the belief that smokers did not require NRT
to quit smoking. Previous studies have shown that
smokers often believe that they will be successful with
smoking cessation without assistance [15,16]. Indeed,
“cold turkey” is the most common method utilised by
both smokers and ex-smokers in their current and previ-
ous quit attempts [17]. Unfortunately, it is also the least
successful method [18]. One way to increase the use of
NRT for harm reduction may therefore be to modify
their control beliefs, i.e. inform smokers that an effective
method of harm reduction and smoking cessation involves
a combination of behavioural and medicinal support, to
tackle both the behavioural and psychological aspects of
the addiction [19].
Additionally, another barrier of the use of medicinal
nicotine for harm reduction was the cost of NRT. Non-
users reported that several factors will encourage them
to use NRT, including being able to collect free samples
to test the effectiveness of the products. However,
University students are a select group and may be more
price-sensitive to the general population [20]. As NRT
for harm reduction is generally obtained over the coun-
ter, rather than on prescription [21], it appears that
income and the cost of NRT are factors that affect the
usage of NRT [10]. Previous studies have suggested that
the usage of NRT may increase if smokers are provided
with free NRT products [22,23], and having NRT pro-
grammes wherein smokers are able to find the NRT
product that is most effective for them through trialling
[24]. These strategies may reduce the social inequalities
found in the use of NRT for harm reduction [25].
Interestingly, misperceptions regarding the safety and
efficacy of NRT persist across all groups, and this acts as
a barrier towards the use of NRT for harm reduction.
This is in line with previous findings on the use of NRT
for smoking reduction and/or temporary abstinence e.g.
[26]. Smokers and ex-smokers were found to hold sub-
stantial concerns about medicinal nicotine which may act
as a barrier towards its use in the long-term, or incorrect
or under-use [27,28] among those who opt for complete
substitution of NRT with cigarettes. Many reported being
concerned about becoming addicted to NRT and were
worried about the health consequences associated with
NRT. These are commonly held beliefs by many smokers
and ex-smokers [29,30]. This is despite the fact that
becoming addicted to medicinal nicotine is rare [31,32]
and that there are few if any health implications [33].
In relation to engaging in harm reduction, all groups
of smokers regretted having started smoking for various
reasons including health effects, and the addictiveness of
cigarettes [34]. However, those who have never used
NRT indicated that they were less likely to have these
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health effects are associated with help seeking behaviour
[35]. Consequently, NRT use for harm reduction may be
more likely among those with health effect concerns. This
relates to our previous finding [10] showing that smokers
concurrently using medicinal nicotine are more motivated
to quit smoking than non-NRT users. The use of NRT not
only helps individuals form the motivation and ‘want’ to
engage in a quit attempt [36], but intervention studies
have also shown that it helps to reduce smoking in
smokers with no interest in quitting [37].
This study has a number of limitations. Firstly, as with
all qualitative work, the findings cannot be generalised to
the wider population as this study focused on a particular
sub-group within the population. Secondly, although
saturation was attained as no new themes emerged from
the last few participants; further themes may have
emerged if a larger sample was used. Thirdly, it is probable
that the interpretation of qualitative data can be subject to
bias and error. Despite this, every effort has been made to
eliminate the occurrence of this by adopting quality assur-
ance techniques to ensure that the interpretation of the
responses accurately reflects the data. Fourthly, even
within the context of qualitative research providing an in-
depth understanding of smokers and ex-smokers attitudes
and beliefs regarding smoking and the use of NRT, the
findings may be limited by the interpretations made and
not having been able to address all the relevant issues.
However, the findings provide information on preliminary
observations that can be further examined using objective
measures.
Conclusions
This study attempts to determine the characteristics of
NRT users and to identify the barriers and facilitators of
NRT use for harm reduction. This study reveals that the
use of NRT is characterized by individuals who are
motivated to quit and willing to engage in the process of
quitting by employing medical and non-medical aids to
assist their quit attempts. NRT users tended to be more
concerned about the health effects of smoking, and this
acted as a motivating factor in the use of NRT. We find a
number of barriers to the general use of NRT, ranging
from misconceptions regarding its safety and efficacy to
the cost of NRT, which may also undermine the use of
NRT for harm reduction. Health professionals need to be
made aware of the need to educate users of these prod-
ucts, not only in terms of their proper application but also
regarding the safety and efficacy within the context of
harm reduction and eventual smoking cessation. In order
to encourage smokers to use NRT for both cessation and
particularly harm reduction purposes, future interventions
should aim to reduce the cost of NRT especially for those
who are unwilling or unable to quit smoking.Additional file
Additional file 1: Themes associated with beliefs about smoking,
quit attempts and cutting down cigarette consumption and the
beliefs, use and concerns about NRT.
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